The accounts of Sorin which closed the third quarter of 2013 with a net result of €14,6 million compared to €0,2 million in the third quarter of 2012. The adjusted net result was €15,7 million compared to €3,1 million in the same period last year .
Revenues also increased, rising to 180,3 million compared to the 160,4 million recorded in the third quarter of 2012. The third quarter of 2013, explains the company, reflects the full recovery from the 2012 earthquake which involved both the oxygenator segment and that of autotransfusion systems.
Net financial debt as at 30 September 2013 was 91,3 million compared to 90,9 million as at 30 June 2013 (89,1 million as at 30 September 2012).
And for the next few months of 2013, Sorin estimates revenue growth at comparable exchange rates of around 5% and an adjusted net result of approximately 58-60 million.
After the publication of the quarterly data, the stock accelerates and registers a rise of more than 2% with a price per share of 2,06.
